Ignite Creation Date:
2024-05-06 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03347422
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2017-11-16
Brief Title:
A Study to Assess the Efficacy and Safety of BIVV009 Sutimlimab in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion
Sponsor:
Organization:
Sanofi